Section Arrow
Quote
NTHI.NASDAQ
- Neonc Technologies Holdings Inc
Quotes are at least 15-min delayed:2026/06/03 16:41 EDT
After Hours
Last
 4.35
0 (0.00%)
Bid
4.34
Ask
6.94
High 4.35 
Low 4.35 
Volume 26 
Regular Hours (Closed)
Last
 4.35
-0.23 (-5.02%)
Day High 
4.8949 
Prev. Close
4.58 
1-M High
6.84 
Volume 
49.27K 
Bid
4.34
Ask
6.94
Day Low
4.16 
Open
4.62 
1-M Low
4 
Market Cap 
119.14M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.01 
20-SMA 5.25 
50-SMA 5.45 
52-W High 12.99 
52-W Low 3.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.80/-0.80
Enterprise Value
119.43M
Balance Sheet
Book Value Per Share
-0.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
39.99K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.0949-0.0149-13.57%-- 
After Hours 0.0939 -0.001 -1.05%
VRAXVirax Biolabs Group Limited0.2401+0.0238+11.00%-- 
After Hours 0.2105 -0.0296 -12.33%
RXRXRecursion Pharmaceuticals3.47-0.14-3.88%-- 
After Hours 3.46 -0.01 -0.29%
CLDICalidi Biotherapeutics0.1656-0.0145-8.05%-- 
After Hours 0.1699 +0.0043 +2.60%
GOSSGossamer Bio0.1883-0.0119-5.94%-- 
After Hours 0.1889 +0.0006 +0.32%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developingdrug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.